Page last updated: 2024-10-25

ciprofloxacin and Urinary Tract Diseases

ciprofloxacin has been researched along with Urinary Tract Diseases in 6 studies

Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.

Research Excerpts

ExcerptRelevanceReference
"Ofloxacin was administered to 18 patients and ciprofloxacin to 17 patients suffering from acute or chronic complicated urinary tract infections."9.06Clinical evaluation of ofloxacin versus ciprofloxacin in complicated urinary tract infections. ( Kromann-Andersen, B; Larsen, V; Pers, C; Rasmussen, F; Sommer, P, 1986)
"Eighty-three patients with serious urinary tract infections were treated with oral ciprofloxacin."7.67Efficacy and safety of oral ciprofloxacin for treatment of serious urinary tract infections. ( Fass, RJ, 1987)
"Ofloxacin was administered to 18 patients and ciprofloxacin to 17 patients suffering from acute or chronic complicated urinary tract infections."5.06Clinical evaluation of ofloxacin versus ciprofloxacin in complicated urinary tract infections. ( Kromann-Andersen, B; Larsen, V; Pers, C; Rasmussen, F; Sommer, P, 1986)
"Eighty-three patients with serious urinary tract infections were treated with oral ciprofloxacin."3.67Efficacy and safety of oral ciprofloxacin for treatment of serious urinary tract infections. ( Fass, RJ, 1987)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19903 (50.00)18.7374
1990's2 (33.33)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ena, J1
Amador, C1
Martinez, C1
Ortiz de la Tabla, V1
Blázquez, R1
Menasalvas, A1
Carpena, I1
Ramírez, C1
Guerrero, C1
Moreno, S1
Christiano, AP1
Hollowell, CM1
Kim, H1
Kim, J1
Patel, R1
Bales, GT1
Gerber, GS1
Newsom, SW1
Kromann-Andersen, B1
Sommer, P1
Pers, C1
Larsen, V1
Rasmussen, F1
Fass, RJ1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Antibiotic Prophylaxis for HDR Brachytherapy in the Treatment of Prostate Cancer: a Phase III Randomized Trial[NCT03862170]Phase 3255 participants (Anticipated)Interventional2015-02-10Suspended (stopped due to Covid-19 pandemic)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

2 trials available for ciprofloxacin and Urinary Tract Diseases

ArticleYear
Double-blind randomized comparison of single-dose ciprofloxacin versus intravenous cefazolin in patients undergoing outpatient endourologic surgery.
    Urology, 2000, Volume: 55, Issue:2

    Topics: Adult; Anti-Infective Agents; Antibiotic Prophylaxis; Cefazolin; Cephalosporins; Chi-Square Distribu

2000
Clinical evaluation of ofloxacin versus ciprofloxacin in complicated urinary tract infections.
    Infection, 1986, Volume: 14 Suppl 4

    Topics: Anti-Infective Agents; Ciprofloxacin; Clinical Trials as Topic; Double-Blind Method; Female; Humans;

1986

Other Studies

4 other studies available for ciprofloxacin and Urinary Tract Diseases

ArticleYear
Risk factors for acquisition of urinary tract infections caused by ciprofloxacin resistant Escherichia coli.
    The Journal of urology, 1995, Volume: 153, Issue:1

    Topics: Age Factors; Aged; Ciprofloxacin; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Inf

1995
Invasive disease caused by ciprofloxacin-resistant uropathogenic Escherichia coli.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1999, Volume: 18, Issue:7

    Topics: Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Escherichia coli; Esc

1999
The clinical use of quinolones.
    Biochemical Society transactions, 1986, Volume: 14, Issue:2

    Topics: Ciprofloxacin; Escherichia coli; Feces; Female; Genital Diseases, Female; Genital Diseases, Male; Hu

1986
Efficacy and safety of oral ciprofloxacin for treatment of serious urinary tract infections.
    Antimicrobial agents and chemotherapy, 1987, Volume: 31, Issue:2

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Ciprofloxacin; Female; Humans; Male; Middle Ag

1987